Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photosensitivity and Keratinocyte Carcinomas in Thai Patients Receiving Voriconazole and Posaconazole (Ambispective Cohort, Phase 1)
TCTR20230210006Unknown
- Sponsor
- Chulalongkorn University
- Start
- Aug 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of voriconazole and posaconazole in Photosensitization and keratinocyte carcinoma, sponsored by Chulalongkorn University. Primary endpoints: Incidence of photosensitivity among voriconazole- and posaconazole-treated patients and Incidence of keratinocyte carcinomas among voriconazole- and posaconazole-treated patients. Status: unknown.
02
Drugs
voriconazoleposaconazole
03
Conditions
Photosensitizationkeratinocyte carcinoma
Beyond the preview
Go deeper on TCTR20230210006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230210006.